193 related articles for article (PubMed ID: 10503906)
1. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms.
Snyderwine EG
Cancer Lett; 1999 Sep; 143(2):211-5. PubMed ID: 10503906
[TBL] [Abstract][Full Text] [Related]
2. Proliferation, development and DNA adduct levels in the mammary gland of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a high fat diet.
Snyderwine EG; Davis CD; Schut HA; Roberts-Thomson SJ
Carcinogenesis; 1998 Jul; 19(7):1209-15. PubMed ID: 9683179
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of rats to mammary gland carcinogenesis by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) varies with age and is associated with the induction of differential gene expression.
Shan L; Yu M; Schut HA; Snyderwine EG
Am J Pathol; 2004 Jul; 165(1):191-202. PubMed ID: 15215175
[TBL] [Abstract][Full Text] [Related]
4. Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Snyderwine EG; Venugopal M; Yu M
Mutat Res; 2002 Sep; 506-507():145-52. PubMed ID: 12351154
[TBL] [Abstract][Full Text] [Related]
5. DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine.
Fretland AJ; Devanaboyina US; Nangju NA; Leff MA; Xiao GH; Webb SJ; Doll MA; Hein DW
J Biochem Mol Toxicol; 2001; 15(1):26-33. PubMed ID: 11170312
[TBL] [Abstract][Full Text] [Related]
6. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) retards mammary gland involution in lactating Sprague-Dawley rats.
Venugopal M; Callaway A; Snyderwine EG
Carcinogenesis; 1999 Jul; 20(7):1309-14. PubMed ID: 10383905
[TBL] [Abstract][Full Text] [Related]
7. Mammary gland carcinogenesis by food-derived heterocyclic amines: metabolism and additional factors influencing carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Snyderwine EG
Environ Mol Mutagen; 2002; 39(2-3):165-70. PubMed ID: 11921185
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats.
Hirose M; Nishikawa A; Shibutani M; Imai T; Shirai T
Environ Mol Mutagen; 2002; 39(2-3):271-8. PubMed ID: 11921198
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanisms for PhIP-DNA adduct formation in the mammary gland of female Sprague-Dawley rats.
Ghoshal A; Davis CD; Schut HA; Snyderwine EG
Carcinogenesis; 1995 Nov; 16(11):2725-31. PubMed ID: 7586192
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3-methylimidazo[4,5-f]quinoline by dietary indole-3-carbinol in female rats.
He YH; Schut HA
J Biochem Mol Toxicol; 1999; 13(5):239-47. PubMed ID: 10402557
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis and DNA adduct formation in the mouse mammary gland exposed to 2-hydroxyamino-1-methyl-6-phenylimidazo-[4,5-b]pyridine in whole organ culture.
Snyderwine EG; Yoon HS; Knight-Jones LP; Tran M; Schut HA; Yu M
Mutagenesis; 2003 Jan; 18(1):7-12. PubMed ID: 12473729
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of conjugated fatty acids derived from safflower or perilla oil of induction and development of mammary tumors in rats induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Futakuchi M; Cheng JL; Hirose M; Kimoto N; Cho YM; Iwata T; Kasai M; Tokudome S; Shirai T
Cancer Lett; 2002 Apr; 178(2):131-9. PubMed ID: 11867197
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity, DNA adduct formation and DNA repair induced by 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline and 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in cultured human mammary epithelial cells.
Fan L; Schut HA; Snyderwine EG
Carcinogenesis; 1995 Apr; 16(4):775-9. PubMed ID: 7728954
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Yu M; Shan L; Snyderwine EG
Oncogene; 2003 Feb; 22(8):1253-60. PubMed ID: 12606953
[TBL] [Abstract][Full Text] [Related]
16. Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.
Yu M; Ryu DY; Snyderwine EG
Mol Carcinog; 2000 Feb; 27(2):76-83. PubMed ID: 10657900
[TBL] [Abstract][Full Text] [Related]
17. H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer.
Yu M; Snyderwine EG
Carcinogenesis; 2002 Dec; 23(12):2123-8. PubMed ID: 12507937
[TBL] [Abstract][Full Text] [Related]
18. A cytogenetic footprint for mammary carcinomas induced by PhIP in rats.
Christian AT
Toxicology; 2002 Dec; 181-182():95-7. PubMed ID: 12505291
[TBL] [Abstract][Full Text] [Related]
19. The effects of 1-nitropyrene, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene on 8-hydroxy-2'-deoxyguanosine levels in the rat mammary gland and modulation by dietary 1,4-phenylenebis(methylene) selenocyanate.
El-Bayoumy K; Chae YH; Rosa JG; Williams LK; Desai D; Amin S; Fiala E
Cancer Lett; 2000 Apr; 151(1):7-13. PubMed ID: 10766416
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets.
Yu M; Jones ML; Gong M; Sinha R; Schut HA; Snyderwine EG
Carcinogenesis; 2002 May; 23(5):877-84. PubMed ID: 12016163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
